Q32 Bio Inc (QTTB) — Capital Reinvestment Ratio
Latest as of September 2023:
0.00x
Q32 Bio Inc (QTTB) has a Capital Reinvestment Ratio of 0.00x as of September 2023, meaning it reinvests 0% of its operating cash flow ($15.90 Million) in capital expenditures ($1.00K). See QTTB net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$15.90 Million
USD
Capital Expenditures
$1.00K
USD
Data as of
Sep 2023
Most recent filing
Q32 Bio Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Q32 Bio Inc's Capital Reinvestment Ratio across 1 annual periods. Check QTTB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Q32 Bio Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Q32 Bio Inc from 2017 to 2017. For live market cap and broader valuation context, see QTTB market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.30x | $6.48 Million | $1.96 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow